Page last updated: 2024-08-24

halofuginone and Malaria, Falciparum

halofuginone has been researched along with Malaria, Falciparum in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bopp, SE; Clish, CB; Deik, AA; Fagbami, L; Herman, JD; Lukens, AK; Mazitschek, R; Santos, SA; Singh, K; Wirth, DF1
Broadbent, KM; Clish, CB; Deik, AA; Desai, MM; Herman, JD; Mazitschek, R; Moss, EL; Neafsey, DE; Ribacke, U; Rice, DP; Silterra, J; Wirth, DF1
Bopp, SE; Clardy, J; Clish, CB; Cortese, JF; Derbyshire, ER; Estiu, G; Galinsky, K; Herman, JD; Keller, TL; Lindquist, S; Lukens, AK; Mazitschek, R; Mota, MM; Patel, V; Pepper, LR; Ribacke, U; Santos, SA; Schimmel, P; Sullivan, WJ; Whitman, M; Wiest, O; Wirth, DF; Zhou, H; Zuzarte-Luis, V1

Other Studies

3 other study(ies) available for halofuginone and Malaria, Falciparum

ArticleYear
The Adaptive Proline Response in P. falciparum Is Independent of PfeIK1 and eIF2α Signaling.
    ACS infectious diseases, 2019, 04-12, Volume: 5, Issue:4

    Topics: Amino Acyl-tRNA Synthetases; Antimalarials; Drug Resistance; Eukaryotic Initiation Factor-2; Humans; Malaria, Falciparum; Phosphorylation; Piperidines; Plasmodium falciparum; Proline; Protozoan Proteins; Quinazolinones; Signal Transduction

2019
A genomic and evolutionary approach reveals non-genetic drug resistance in malaria.
    Genome biology, 2014, Volume: 15, Issue:11

    Topics: Biological Evolution; Drug Resistance; Genomics; Humans; Malaria, Falciparum; Mutation; Piperidines; Plasmodium falciparum; Protozoan Proteins; Quinazolinones; Sequence Analysis, DNA

2014
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
    Science translational medicine, 2015, May-20, Volume: 7, Issue:288

    Topics: Amino Acyl-tRNA Synthetases; Animals; Antimalarials; Computer-Aided Design; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Resistance; Enzyme Inhibitors; Erythrocytes; Liver; Malaria, Falciparum; Mice; Models, Molecular; Molecular Structure; Molecular Targeted Therapy; Piperidines; Plasmodium falciparum; Protozoan Proteins; Quinazolines; Quinazolinones; Structure-Activity Relationship; Time Factors

2015